Indication

Rare Lesion

1 clinical trial

1 product

1 drug

Clinical trial

A Phase II, Open-Label, Single-Arm, Multi-Cohort, Proof-of-Principle Study to Investigate the Efficacy of Cobimetinib and Atezolizumab in Advanced Rare Tumors

Status: Completed, Estimated PCD: 2024-04-02

Drug

Product